LRRC36
geneOn this page
Also known as FLJ11004
Summary
LRRC36 (leucine rich repeat containing 36, HGNC:25615) is a protein-coding gene on chromosome 16q22.1, encoding Leucine-rich repeat-containing protein 36 (Q1X8D7).
At a glance
- GWAS associations: 15
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_018296
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25615 |
| Approved symbol | LRRC36 |
| Name | leucine rich repeat containing 36 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ11004 |
| Ensembl gene | ENSG00000159708 |
| Ensembl biotype | protein_coding |
| Entrez | 55282 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 8 nonsense_mediated_decay, 6 protein_coding, 2 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000329956, ENST00000435835, ENST00000561821, ENST00000561948, ENST00000563189, ENST00000563303, ENST00000565019, ENST00000566558, ENST00000567211, ENST00000567723, ENST00000567823, ENST00000568010, ENST00000568804, ENST00000569121, ENST00000569228, ENST00000569499, ENST00000569552, ENST00000570075
RefSeq mRNA: 2 — MANE Select: NM_018296
NM_001161575, NM_018296
CCDS: CCDS32467, CCDS58474
Canonical transcript exons
ENST00000329956 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003472999 | 67378589 | 67378712 |
| ENSE00003492862 | 67341957 | 67342084 |
| ENSE00003496405 | 67347495 | 67347591 |
| ENSE00003520373 | 67382133 | 67382247 |
| ENSE00003531770 | 67376727 | 67376872 |
| ENSE00003567852 | 67363590 | 67363714 |
| ENSE00003577154 | 67367017 | 67367457 |
| ENSE00003577266 | 67375247 | 67375412 |
| ENSE00003621280 | 67370944 | 67371242 |
| ENSE00003634107 | 67346256 | 67346448 |
| ENSE00003645190 | 67350202 | 67350290 |
| ENSE00003789961 | 67365304 | 67365355 |
| ENSE00003841346 | 67384870 | 67385204 |
| ENSE00003841406 | 67326815 | 67326932 |
Expression profiles
Bgee: expression breadth ubiquitous, 171 present calls, max score 94.53.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2569 / max 50.5215, expressed in 78 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154616 | 0.1212 | 32 |
| 154617 | 0.0719 | 18 |
| 154618 | 0.0455 | 23 |
| 154620 | 0.0113 | 4 |
| 154619 | 0.0070 | 3 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 94.53 | gold quality |
| right testis | UBERON:0004534 | 94.35 | gold quality |
| testis | UBERON:0000473 | 91.72 | gold quality |
| right uterine tube | UBERON:0001302 | 90.55 | gold quality |
| sperm | CL:0000019 | 89.42 | gold quality |
| male germ cell | CL:0000015 | 88.48 | gold quality |
| adult organism | UBERON:0007023 | 86.02 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 84.63 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.56 | gold quality |
| bronchial epithelial cell | CL:0002328 | 84.36 | gold quality |
| bronchus | UBERON:0002185 | 84.00 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.91 | gold quality |
| right lung | UBERON:0002167 | 81.43 | gold quality |
| pancreatic ductal cell | CL:0002079 | 79.68 | silver quality |
| lung | UBERON:0002048 | 78.95 | gold quality |
| placenta | UBERON:0001987 | 78.13 | gold quality |
| oviduct epithelium | UBERON:0004804 | 77.28 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 76.97 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 76.03 | gold quality |
| upper lobe of lung | UBERON:0008948 | 75.84 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 74.78 | gold quality |
| fallopian tube | UBERON:0003889 | 74.09 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 73.67 | silver quality |
| lower lobe of lung | UBERON:0008949 | 73.43 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 73.26 | gold quality |
| type B pancreatic cell | CL:0000169 | 72.36 | gold quality |
| visceral pleura | UBERON:0002401 | 72.20 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.82 | gold quality |
| olfactory bulb | UBERON:0002264 | 71.44 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 71.23 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 14.51 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
3 targeting LRRC36, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-4800-5P | 97.22 | 65.91 | 324 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lrrc36 | ENSMUSG00000054320 |
| rattus_norvegicus | Lrrc36 | ENSRNOG00000016854 |
Paralogs (1): CEP72 (ENSG00000112877)
Protein
Protein identifiers
Leucine-rich repeat-containing protein 36 — Q1X8D7 (reviewed: Q1X8D7)
Alternative names: ROR gamma-binding protein 70
All UniProt accessions (10): Q1X8D7, H3BND7, H3BNV0, H3BQI9, H3BRB2, H3BRP7, H3BS33, H3BSQ6, J3QRT0, J3QSG3
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q1X8D7-1 | 1 | yes |
| Q1X8D7-2 | 2 | |
| Q1X8D7-3 | 3 |
RefSeq proteins (2): NP_001155047, NP_060766* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR055320 | CEP72-like | Family |
Pfam: PF14580
UniProt features (18 total): splice variant 5, sequence variant 3, repeat 2, region of interest 2, compositionally biased region 2, chain 1, sequence conflict 1, domain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q1X8D7-F1 | 55.05 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, chr16q22, AP2_Q3, AP2GAMMA_01, E2A_Q2, ATGGYGGA_UNKNOWN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, CHYLA_CBFA2T3_TARGETS_DN, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12, PRC1_BMI_UP.V1_DN, ZNF2_TARGET_GENES, ZNF274_TARGET_GENES, ZNF512_TARGET_GENES, ZNF843_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
358 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC36 | C16orf86 | Q6ZW13 | 478 |
| LRRC36 | KCTD19 | Q17RG1 | 475 |
| LRRC36 | MS4A5 | Q9H3V2 | 435 |
| LRRC36 | ZNF391 | Q9UJN7 | 400 |
| LRRC36 | SPATA31G1 | Q5VYM1 | 380 |
| LRRC36 | ZDHHC1 | Q8WTX9 | 373 |
| LRRC36 | TSNAXIP1 | Q2TAA8 | 370 |
| LRRC36 | C5orf34 | Q96MH7 | 359 |
| LRRC36 | CCDC13 | Q8IYE1 | 349 |
| LRRC36 | TMEM125 | Q96AQ2 | 348 |
| LRRC36 | TCEAL3 | Q969E4 | 336 |
| LRRC36 | PNLIPRP3 | Q17RR3 | 324 |
| LRRC36 | ZNF804B | A4D1E1 | 322 |
| LRRC36 | IER5L | Q5T953 | 307 |
| LRRC36 | PARD6A | Q9NPB6 | 305 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRC36 | TEX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC36 | SUCLA2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| LRRC36 | H1-1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| LRRC36 | TBL1X | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC36 | TEX11 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): ISCA1 (Affinity Capture-MS), SNX27 (Affinity Capture-MS), SUFU (Affinity Capture-MS), GOLGA3 (Affinity Capture-MS), TBL1X (Affinity Capture-MS), CNDP2 (Affinity Capture-MS), HSPA9 (Affinity Capture-MS), LRRC36 (Two-hybrid), LRRC36 (Proximity Label-MS), SUCLA2 (Proximity Label-MS), SUGT1 (Affinity Capture-MS), SNX27 (Affinity Capture-MS), SUFU (Affinity Capture-MS), HSPA8 (Affinity Capture-MS), CNDP2 (Affinity Capture-MS)
ESM2 similar proteins: A0A140LFM6, A0A1B0GVH6, A0A1L8H8C0, A0A2K1JJ00, A0JMD2, A2ARZ3, A2AWL7, A4IGV6, A6H5Y1, D3ZJ47, E9Q309, F1QPR4, F5H4B4, H0WFA5, O14513, O35413, O94875, P0CAX8, P48437, Q12912, Q15468, Q1LXZ9, Q1X8D7, Q28FG2, Q3UTJ2, Q3ZBS1, Q499E5, Q49A88, Q4V7H1, Q5T5U3, Q5VT06, Q62417, Q62770, Q69Z38, Q6DFB0, Q80TY4, Q8BLN6, Q8CB14, Q8IWI9, Q8K0T7
Diamond homologs: B6CZ40, B6CZ45, B6CZ54, B6CZ61, D4AC13, O35125, O43822, P34390, Q1X8D7, Q28CU0, Q32KP2, Q3UVD5, Q3V0M2, Q53EV4, Q5EAD8, Q8C6G1, Q96E66, Q9DAK8, Q9HBX8, Q9U1H9, B3NLX1, B4GT53, B4P6W7, B6D5P1, B6D5P3, B6D5P6, Q09JZ4, Q16RY9, Q29KL8, Q3SYS4, Q6AYH9, Q7PK92, Q7ZV84, Q8INT5, Q8NEP3, Q9D2H9, Q9D3R3, Q501X2, Q8CDN9, Q9BLB6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 83 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2377 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:67372665:G:GT | donor_gain | 1.0000 |
| 16:67375409:CTCGG:C | donor_loss | 1.0000 |
| 16:67375410:TCGG:T | donor_loss | 1.0000 |
| 16:67375413:G:GC | donor_loss | 1.0000 |
| 16:67375413:G:GG | donor_gain | 1.0000 |
| 16:67375414:TGAG:T | donor_loss | 1.0000 |
| 16:67375415:GAGT:G | donor_loss | 1.0000 |
| 16:67378580:A:AG | acceptor_gain | 1.0000 |
| 16:67378581:A:G | acceptor_gain | 1.0000 |
| 16:67346318:A:AG | acceptor_gain | 0.9900 |
| 16:67346319:G:GG | acceptor_gain | 0.9900 |
| 16:67346391:A:T | donor_gain | 0.9900 |
| 16:67363587:C:G | acceptor_gain | 0.9900 |
| 16:67375243:T:TA | acceptor_gain | 0.9900 |
| 16:67378585:A:AG | acceptor_gain | 0.9900 |
| 16:67378585:AAAG:A | acceptor_gain | 0.9900 |
| 16:67378586:A:G | acceptor_gain | 0.9900 |
| 16:67378588:GGAAA:G | acceptor_gain | 0.9900 |
| 16:67378709:TATGG:T | donor_loss | 0.9900 |
| 16:67378710:ATGGT:A | donor_loss | 0.9900 |
| 16:67378711:TGGTA:T | donor_loss | 0.9900 |
| 16:67378713:G:GT | donor_loss | 0.9900 |
| 16:67378714:TA:T | donor_loss | 0.9900 |
| 16:67378715:AAGTT:A | donor_loss | 0.9900 |
| 16:67382112:T:TA | acceptor_gain | 0.9900 |
| 16:67382245:GAG:G | donor_gain | 0.9900 |
| 16:67384860:T:A | acceptor_gain | 0.9900 |
| 16:67384861:G:A | acceptor_gain | 0.9900 |
| 16:67347493:A:AG | acceptor_gain | 0.9800 |
| 16:67347494:G:GG | acceptor_gain | 0.9800 |
AlphaMissense
4899 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:67346287:T:C | L77P | 1.000 |
| 16:67342050:T:C | L55S | 0.999 |
| 16:67342056:T:C | L57S | 0.999 |
| 16:67342066:T:A | N60K | 0.999 |
| 16:67342066:T:G | N60K | 0.999 |
| 16:67346303:C:A | N82K | 0.999 |
| 16:67346303:C:G | N82K | 0.999 |
| 16:67346335:T:C | L93P | 0.999 |
| 16:67346362:T:C | L102P | 0.999 |
| 16:67346368:T:C | L104S | 0.999 |
| 16:67346378:T:A | N107K | 0.999 |
| 16:67346378:T:G | N107K | 0.999 |
| 16:67346383:T:A | V109D | 0.999 |
| 16:67346416:C:A | A120D | 0.999 |
| 16:67347531:C:A | A143D | 0.999 |
| 16:67341983:G:A | G33R | 0.998 |
| 16:67341983:G:C | G33R | 0.998 |
| 16:67342041:T:A | L52H | 0.998 |
| 16:67342064:A:G | N60D | 0.998 |
| 16:67342065:A:T | N60I | 0.998 |
| 16:67346256:G:A | G67R | 0.998 |
| 16:67346256:G:C | G67R | 0.998 |
| 16:67346278:T:A | L74H | 0.998 |
| 16:67346287:T:A | L77Q | 0.998 |
| 16:67346302:A:T | N82I | 0.998 |
| 16:67346371:G:C | R105T | 0.998 |
| 16:67346371:G:T | R105I | 0.998 |
| 16:67346372:A:C | R105S | 0.998 |
| 16:67346372:A:T | R105S | 0.998 |
| 16:67346374:T:C | L106P | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000032410 (16:67373386 G>A), RS1000188109 (16:67345637 A>G), RS1000261016 (16:67343595 T>C), RS1000261454 (16:67380896 T>A,C), RS1000297597 (16:67324985 G>C), RS1000471328 (16:67330115 C>T), RS1000479167 (16:67334683 C>T), RS1000486541 (16:67351337 C>T), RS1000636988 (16:67343222 C>G,T), RS1000772788 (16:67353230 A>G), RS1000879075 (16:67366324 T>A,G), RS1000896022 (16:67358754 A>G), RS1000926857 (16:67343537 A>G), RS1000955220 (16:67356732 A>G), RS1000963961 (16:67364076 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
15 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004562_153 | Waist circumference adjusted for body mass index | 4.000000e-09 |
| GCST004563_30 | Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) | 2.000000e-08 |
| GCST004564_7 | Waist circumference adjusted for BMI in active individuals | 8.000000e-08 |
| GCST007483_14 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 6.000000e-13 |
| GCST007483_17 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 4.000000e-13 |
| GCST007487_30 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 7.000000e-11 |
| GCST007487_35 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 4.000000e-11 |
| GCST007492_8 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 6.000000e-06 |
| GCST007492_9 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 2.000000e-06 |
| GCST007500_24 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 4.000000e-09 |
| GCST007500_27 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 1.000000e-08 |
| GCST007502_23 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 3.000000e-09 |
| GCST007502_24 | Waist-to-hip ratio adjusted for BMI (additive genetic model) | 8.000000e-09 |
| GCST010002_113 | Refractive error | 2.000000e-14 |
| GCST010571_65 | Autoimmune thyroid disease | 2.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0008002 | physical activity measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| propionaldehyde | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Phthalic Acids | increases methylation | 1 |
| Rotenone | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Asbestos, Crocidolite | affects methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): autoimmune thyroid disease